JCGGDB TOP GlycoScience Protocol Online Database

Enzyme assay of sulfotransferases for heparan sulfate
Text Search

Enzyme assay of sulfotransferases for heparan sulfate

Authors:
Introduction Protocol References Credit lines
Category
Glycosyltransferases & related proteins
Protocol Name

Enzyme assay of sulfotransferases for heparan sulfate

Authors
Habuchi, Hiroko *
Advanced Medical Research Center, Aichi Medical University

Kimata, Koji
Research Complex for the Medicine Frontiers, Aichi Medical University
*To whom correspondence should be addressed.
KeyWords
Reagents

[35 S]PAPS (10,000 cpm/pmol)(PerkinElmer, Waltham, MA, NEG010)

Chondroitin sulfate A (Seikagaku Corp., Tokyo, Japan)

Completely desulfated and N-resulfated heparin (CDSNS-heparin) or CDSNS-HS (Seikagaku Corp.)

N-desulfated heparin (see Notes 1)

Unsaturated heparan sulfate/heparin disaccharide mixture (H mix) (Seikagaku Corp.)

Heparitinase I (Seikagaku Corp.)

Heparitinase II (Seikagaku Corp.)

Heparinase (Seikagaku Corp.)

Ready Safe Scintillator (Beckman Coulter, Inc., Brea, CA)

pFLAG-CMV-2 vector (Sigma-Aldrich, St. Louis, MO)

FLAG M2 antibody-conjugated agarose (Sigma-Aldrich)

Instruments

YMC-Pack Polyamine II column (4.6 mm × 25 cm) (YMC Co., Ltd., Kyoto, Japan)

Fast Desalting Column HR 10/10 (GE Healthcare, Little Chalfont, UK) (see Notes 2)

Sepadex G-50 medium (Invitrogen/Life Technologies, Carlsbad, CA)

Liquid scintilation counter

HPLC system

Methods
1.

Enzyme assay of heparan sulfate 2-O-sulfotransferase (HS2ST), heparan sulfate 6-O-sulfotransferases (HS6STs) and heparan sulfate N-sulfotransferases (NDSTs)

1) 

 Prepare the recombinant enzymes.

Comment 1
2) 

 Prepare the reaction mixture (50 μL) containing 2.5 μmol of imidazole-HCl, pH 5.6 (for HS2ST) or pH 6.3 (for HS6STs), 3.75 μg of protamine chloride, 25 nmol (as hexuronic acid) of CDSNS-heparin or other glycosaminoglycans, 50 pmol [35S]PAPS (about 5 × 105 cpm), 5 μL of 1 M NaCl in buffer A (10 mM Tris-HCl, pH 7.2, 0.1% Trton X-100, 10 mM MgCl2, 2 mM CaCl2, 20% (V/V) glycerol), and enzyme (Note 1-3). As to NDSTs, the reaction mixture (50 μL) contains 2.5 μmol of HEPES, pH 7.0, 0.1% Triton X-100, 0.5 μmol MgCl2, 0.05 μmol MnCl2, 25 μg of N-desulfated heparin, 50 pmol [35S]PAPS (about 5 × 105 cpm), and enzyme.

Comment 0
3) 

 Incubate at 37ºC for 20 min.

Comment 0
4) 

 Stop the reaction by heating at 100ºC for 1 min.

Comment 0
5) 

 Add chondroitin sulfate A as carrier (0.1 μmol as GlcA) to the reaction mixture and vortex well.

Comment 0
6) 

 Add 2.5 vol. of cold 95% ethanol/1.3% (w/v) potassium acetate/0.5 mM EDTA to the reaction mixture, and vortex well and then keep at −20ºC for 30 min.

Comment 0
7) 

 Precipitate 35S-labeled polysaccharides by centrifugation at 10,000 × g for 30 min and discard the supernatant.

Comment 0
8) 

 Add 70 μL of distilled in the precipitates and vortex well.

Comment 1
9) 

 Inject 50 μL of the solution into a Fast Desalting column equilibrated with 0.2 M NH4HCO3 at a flow rate of 2 mL/min.

Comment 1
10) 

 Collect the void volume to recover 35S-labeled products and mix with 3 mL of Scintillator, and determine the radioactivity by a liquid scintillation counter.

Comment 0
2.

Determination of sulfated positions in the products

1) 

 Digest 35S-labeled products with a mixture of heparitinase I, heparitinase II and heparinase.

Comment 1
2) 

 Stop the reaction by heating at 100ºC for 1 min.

Comment 0
3) 

 Inject the digests together with 1 nmole of standard unsaturated disaccharides into a column of YMC-Pack Polyamine II. HPLC is performd* and the elution is fractionated into 0.6 mL portions to separate unsaturated disaccharide.

Comment 1
4) 

 Each fraction is mixed with 3 mL of Ready Safe scintillator, and determine radioactivities of the fractions containing ∆HexA(2SO4)-GlcNSO3 for HS2ST and ∆HexA-GlcNSO3(6SO4) for HS6ST-1, -2, and -3, respectively.

Comment 0
Notes
  1. Chemically N-desulfated heparin is obtained from heparin (Sigma-Aldrich) by solvolysis with DMSO 6). Solvolysis with 5% (v/v) methanol in DMSO is performed at 50ºC for 1.5 h.
  2. Instead of a Fast Desalting column, a spin column can be utilized. The spin column (bed volume 0.9 mL) is prepared by packing Sephadex G-50 medium (GE Healthcare) suspended in 0.1 M NH4HCO3 into 1 mL syringe under centrifugation at 2,000 rpm for 4 min. A spin column is also commercially available 7). Samples (100 μL) are loaded to the top of the gel and centrifuged at 2,000 rpm for 4 min. [35S]Glycosaminoglycans are recovered in the flow through fractions.
  3. When crude extracts are used as enzyme, 1 μmole NaF and 0.1 μmole AMP are added to the reaction mixture to prevent degradation of PAPS.
  4. HS6ST isoforms but not HS2ST are inhibited by DTT. HS6ST-1 activity is decreased to 19% of control in 10 mM DTT.
  5. As to the sensitivity of this assay, crude extract from 1 × 105 fibroblasts (no transfection, endogenous activity) is enough to determine HS2ST and HS6ST activities.
Copyrights Creative Commons License   Attribution-Non-Commercial Share Alike
This work is released underCreative Commons licenses
Date of registration:2014-07-31 09:28:45
©2010 - 2023 Ritsumeikan University, AIST & JCGGDB. All Rights Reserved